nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CHRFAM7A—corpus luteum—ovarian cancer	0.0812	0.234	CbGeAlD
Primidone—CHRNA7—corpus luteum—ovarian cancer	0.0656	0.189	CbGeAlD
Primidone—CHRFAM7A—ovarian follicle—ovarian cancer	0.0635	0.183	CbGeAlD
Primidone—CHRNA7—ovarian follicle—ovarian cancer	0.0513	0.148	CbGeAlD
Primidone—CYP2C8—Paclitaxel—ovarian cancer	0.0379	0.212	CbGbCtD
Primidone—CYP3A4—Topotecan—ovarian cancer	0.031	0.174	CbGbCtD
Primidone—CYP2B6—Doxorubicin—ovarian cancer	0.0269	0.151	CbGbCtD
Primidone—CYP2C9—Paclitaxel—ovarian cancer	0.0264	0.148	CbGbCtD
Primidone—CYP3A4—Vinorelbine—ovarian cancer	0.0218	0.122	CbGbCtD
Primidone—CYP3A4—Paclitaxel—ovarian cancer	0.0154	0.0859	CbGbCtD
Primidone—Ataxia—Altretamine—ovarian cancer	0.014	0.0407	CcSEcCtD
Primidone—CYP3A4—Docetaxel—ovarian cancer	0.0111	0.0621	CbGbCtD
Primidone—GRIA2—embryo—ovarian cancer	0.00942	0.0272	CbGeAlD
Primidone—Anaemia—Altretamine—ovarian cancer	0.00831	0.0241	CcSEcCtD
Primidone—CYP3A4—Doxorubicin—ovarian cancer	0.00827	0.0463	CbGbCtD
Primidone—Vertigo—Altretamine—ovarian cancer	0.00808	0.0234	CcSEcCtD
Primidone—Anorexia—Altretamine—ovarian cancer	0.007	0.0203	CcSEcCtD
Primidone—Systemic lupus erythematosus—Paclitaxel—ovarian cancer	0.00677	0.0196	CcSEcCtD
Primidone—Decreased appetite—Altretamine—ovarian cancer	0.00638	0.0185	CcSEcCtD
Primidone—Fatigue—Altretamine—ovarian cancer	0.00633	0.0184	CcSEcCtD
Primidone—Systemic lupus erythematosus—Docetaxel—ovarian cancer	0.00574	0.0166	CcSEcCtD
Primidone—Asthenia—Altretamine—ovarian cancer	0.00527	0.0153	CcSEcCtD
Primidone—CHRFAM7A—female reproductive system—ovarian cancer	0.00521	0.015	CbGeAlD
Primidone—Eruption—Docetaxel—ovarian cancer	0.00516	0.015	CcSEcCtD
Primidone—Ataxia—Chlorambucil—ovarian cancer	0.00499	0.0145	CcSEcCtD
Primidone—Dizziness—Altretamine—ovarian cancer	0.00486	0.0141	CcSEcCtD
Primidone—CHRFAM7A—female gonad—ovarian cancer	0.00474	0.0137	CbGeAlD
Primidone—CHRNA7—uterus—ovarian cancer	0.00468	0.0135	CbGeAlD
Primidone—Vomiting—Altretamine—ovarian cancer	0.00467	0.0135	CcSEcCtD
Primidone—GRIA2—testis—ovarian cancer	0.00461	0.0133	CbGeAlD
Primidone—Blood disorder—Paclitaxel—ovarian cancer	0.00449	0.013	CcSEcCtD
Primidone—Nausea—Altretamine—ovarian cancer	0.00436	0.0126	CcSEcCtD
Primidone—GABRA5—testis—ovarian cancer	0.00432	0.0125	CbGeAlD
Primidone—CHRNA7—female reproductive system—ovarian cancer	0.0042	0.0121	CbGeAlD
Primidone—CHRFAM7A—testis—ovarian cancer	0.0042	0.0121	CbGeAlD
Primidone—GABRA3—testis—ovarian cancer	0.00402	0.0116	CbGeAlD
Primidone—CHRNA7—female gonad—ovarian cancer	0.00383	0.011	CbGeAlD
Primidone—Eruption—Epirubicin—ovarian cancer	0.00348	0.0101	CcSEcCtD
Primidone—CHRNA7—testis—ovarian cancer	0.00339	0.00979	CbGeAlD
Primidone—GABRA2—vagina—ovarian cancer	0.00336	0.00969	CbGeAlD
Primidone—GABRB2—testis—ovarian cancer	0.00328	0.00946	CbGeAlD
Primidone—Eruption—Doxorubicin—ovarian cancer	0.00322	0.00934	CcSEcCtD
Primidone—Connective tissue disorder—Melphalan—ovarian cancer	0.00315	0.00912	CcSEcCtD
Primidone—Nystagmus—Epirubicin—ovarian cancer	0.003	0.0087	CcSEcCtD
Primidone—Anaemia—Chlorambucil—ovarian cancer	0.00296	0.00857	CcSEcCtD
Primidone—Agranulocytosis—Vinorelbine—ovarian cancer	0.00291	0.00843	CcSEcCtD
Primidone—Visual disturbance—Paclitaxel—ovarian cancer	0.00287	0.00832	CcSEcCtD
Primidone—CYP2C8—endometrium—ovarian cancer	0.00285	0.00822	CbGeAlD
Primidone—Malnutrition—Topotecan—ovarian cancer	0.00285	0.00826	CcSEcCtD
Primidone—Nystagmus—Doxorubicin—ovarian cancer	0.00277	0.00805	CcSEcCtD
Primidone—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00275	0.00797	CcSEcCtD
Primidone—Anaemia—Topotecan—ovarian cancer	0.00263	0.00763	CcSEcCtD
Primidone—Anaemia—Melphalan—ovarian cancer	0.00258	0.00747	CcSEcCtD
Primidone—Blood disorder—Epirubicin—ovarian cancer	0.00256	0.00744	CcSEcCtD
Primidone—Ataxia—Paclitaxel—ovarian cancer	0.00256	0.00742	CcSEcCtD
Primidone—Anorexia—Chlorambucil—ovarian cancer	0.00249	0.00721	CcSEcCtD
Primidone—CYP2C19—vagina—ovarian cancer	0.00244	0.00705	CbGeAlD
Primidone—Malnutrition—Vinorelbine—ovarian cancer	0.00243	0.00706	CcSEcCtD
Primidone—Visual disturbance—Docetaxel—ovarian cancer	0.00243	0.00705	CcSEcCtD
Primidone—Arthralgia—Topotecan—ovarian cancer	0.00242	0.00703	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00241	0.00698	CcSEcCtD
Primidone—Blood disorder—Doxorubicin—ovarian cancer	0.00237	0.00688	CcSEcCtD
Primidone—CYP2B6—gonad—ovarian cancer	0.00237	0.00684	CbGeAlD
Primidone—CYP2C8—female reproductive system—ovarian cancer	0.00236	0.00681	CbGeAlD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00236	0.00683	CcSEcCtD
Primidone—Nervous system disorder—Topotecan—ovarian cancer	0.00228	0.00661	CcSEcCtD
Primidone—Decreased appetite—Chlorambucil—ovarian cancer	0.00227	0.00658	CcSEcCtD
Primidone—Skin disorder—Topotecan—ovarian cancer	0.00226	0.00654	CcSEcCtD
Primidone—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00225	0.00653	CcSEcCtD
Primidone—Anaemia—Vinorelbine—ovarian cancer	0.00225	0.00653	CcSEcCtD
Primidone—Fatigue—Chlorambucil—ovarian cancer	0.00225	0.00653	CcSEcCtD
Primidone—Anorexia—Topotecan—ovarian cancer	0.00221	0.00642	CcSEcCtD
Primidone—Skin disorder—Melphalan—ovarian cancer	0.00221	0.00641	CcSEcCtD
Primidone—Vertigo—Vinorelbine—ovarian cancer	0.00219	0.00634	CcSEcCtD
Primidone—GABRA2—lymph node—ovarian cancer	0.00217	0.00627	CbGeAlD
Primidone—Anorexia—Melphalan—ovarian cancer	0.00217	0.00629	CcSEcCtD
Primidone—Ataxia—Docetaxel—ovarian cancer	0.00217	0.00629	CcSEcCtD
Primidone—CYP2C8—vagina—ovarian cancer	0.00213	0.00616	CbGeAlD
Primidone—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00212	0.00614	CcSEcCtD
Primidone—CYP2B6—female reproductive system—ovarian cancer	0.00212	0.00611	CbGeAlD
Primidone—CYP2C9—female reproductive system—ovarian cancer	0.00209	0.00605	CbGeAlD
Primidone—Depression—Paclitaxel—ovarian cancer	0.00209	0.00606	CcSEcCtD
Primidone—Arthralgia—Vinorelbine—ovarian cancer	0.00207	0.00601	CcSEcCtD
Primidone—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00207	0.00601	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00206	0.00597	CcSEcCtD
Primidone—Decreased appetite—Topotecan—ovarian cancer	0.00202	0.00586	CcSEcCtD
Primidone—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00201	0.00582	CcSEcCtD
Primidone—Fatigue—Topotecan—ovarian cancer	0.002	0.00581	CcSEcCtD
Primidone—Decreased appetite—Melphalan—ovarian cancer	0.00198	0.00573	CcSEcCtD
Primidone—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00196	0.0057	CcSEcCtD
Primidone—Fatigue—Melphalan—ovarian cancer	0.00196	0.00569	CcSEcCtD
Primidone—Nervous system disorder—Vinorelbine—ovarian cancer	0.00195	0.00565	CcSEcCtD
Primidone—Skin disorder—Vinorelbine—ovarian cancer	0.00193	0.0056	CcSEcCtD
Primidone—CYP2B6—vagina—ovarian cancer	0.00191	0.00552	CbGeAlD
Primidone—CYP2C8—testis—ovarian cancer	0.0019	0.00549	CbGeAlD
Primidone—Anorexia—Vinorelbine—ovarian cancer	0.00189	0.00549	CcSEcCtD
Primidone—Asthenia—Chlorambucil—ovarian cancer	0.00187	0.00543	CcSEcCtD
Primidone—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00185	0.00536	CcSEcCtD
Primidone—Visual impairment—Paclitaxel—ovarian cancer	0.00181	0.00526	CcSEcCtD
Primidone—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00181	0.00525	CcSEcCtD
Primidone—Eye disorder—Paclitaxel—ovarian cancer	0.00176	0.0051	CcSEcCtD
Primidone—Decreased appetite—Vinorelbine—ovarian cancer	0.00173	0.00501	CcSEcCtD
Primidone—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00172	0.00498	CcSEcCtD
Primidone—Fatigue—Vinorelbine—ovarian cancer	0.00171	0.00497	CcSEcCtD
Primidone—CYP2B6—testis—ovarian cancer	0.00171	0.00493	CbGeAlD
Primidone—Asthenia—Topotecan—ovarian cancer	0.00167	0.00483	CcSEcCtD
Primidone—Vomiting—Chlorambucil—ovarian cancer	0.00166	0.00481	CcSEcCtD
Primidone—Agranulocytosis—Docetaxel—ovarian cancer	0.00166	0.00481	CcSEcCtD
Primidone—Mental disorder—Paclitaxel—ovarian cancer	0.00165	0.00478	CcSEcCtD
Primidone—Malnutrition—Paclitaxel—ovarian cancer	0.00164	0.00475	CcSEcCtD
Primidone—Asthenia—Melphalan—ovarian cancer	0.00163	0.00473	CcSEcCtD
Primidone—Phenobarbital—CYP1B1—ovarian cancer	0.0016	0.63	CrCbGaD
Primidone—CYP3A4—female reproductive system—ovarian cancer	0.0016	0.00461	CbGeAlD
Primidone—Connective tissue disorder—Docetaxel—ovarian cancer	0.00157	0.00454	CcSEcCtD
Primidone—Diplopia—Epirubicin—ovarian cancer	0.00155	0.00451	CcSEcCtD
Primidone—Nausea—Chlorambucil—ovarian cancer	0.00155	0.0045	CcSEcCtD
Primidone—Visual impairment—Docetaxel—ovarian cancer	0.00154	0.00446	CcSEcCtD
Primidone—Dizziness—Topotecan—ovarian cancer	0.00154	0.00446	CcSEcCtD
Primidone—Anaemia—Paclitaxel—ovarian cancer	0.00151	0.00439	CcSEcCtD
Primidone—Eye disorder—Docetaxel—ovarian cancer	0.00149	0.00432	CcSEcCtD
Primidone—Vomiting—Topotecan—ovarian cancer	0.00148	0.00428	CcSEcCtD
Primidone—Vertigo—Paclitaxel—ovarian cancer	0.00147	0.00427	CcSEcCtD
Primidone—Rash—Topotecan—ovarian cancer	0.00146	0.00425	CcSEcCtD
Primidone—Dermatitis—Topotecan—ovarian cancer	0.00146	0.00424	CcSEcCtD
Primidone—Ataxia—Epirubicin—ovarian cancer	0.00146	0.00424	CcSEcCtD
Primidone—Headache—Topotecan—ovarian cancer	0.00146	0.00422	CcSEcCtD
Primidone—Vomiting—Melphalan—ovarian cancer	0.00145	0.00419	CcSEcCtD
Primidone—Diplopia—Doxorubicin—ovarian cancer	0.00144	0.00417	CcSEcCtD
Primidone—Rash—Melphalan—ovarian cancer	0.00143	0.00416	CcSEcCtD
Primidone—Dermatitis—Melphalan—ovarian cancer	0.00143	0.00416	CcSEcCtD
Primidone—Asthenia—Vinorelbine—ovarian cancer	0.00143	0.00414	CcSEcCtD
Primidone—Mental disorder—Docetaxel—ovarian cancer	0.0014	0.00405	CcSEcCtD
Primidone—Arthralgia—Paclitaxel—ovarian cancer	0.00139	0.00404	CcSEcCtD
Primidone—Malnutrition—Docetaxel—ovarian cancer	0.00139	0.00403	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00138	0.00402	CcSEcCtD
Primidone—Nausea—Topotecan—ovarian cancer	0.00138	0.004	CcSEcCtD
Primidone—Ataxia—Doxorubicin—ovarian cancer	0.00135	0.00392	CcSEcCtD
Primidone—Nausea—Melphalan—ovarian cancer	0.00135	0.00392	CcSEcCtD
Primidone—Dizziness—Vinorelbine—ovarian cancer	0.00131	0.00381	CcSEcCtD
Primidone—Nervous system disorder—Paclitaxel—ovarian cancer	0.00131	0.0038	CcSEcCtD
Primidone—Skin disorder—Paclitaxel—ovarian cancer	0.0013	0.00377	CcSEcCtD
Primidone—Anaemia—Docetaxel—ovarian cancer	0.00128	0.00372	CcSEcCtD
Primidone—Anorexia—Paclitaxel—ovarian cancer	0.00127	0.0037	CcSEcCtD
Primidone—Vomiting—Vinorelbine—ovarian cancer	0.00126	0.00366	CcSEcCtD
Primidone—Rash—Vinorelbine—ovarian cancer	0.00125	0.00363	CcSEcCtD
Primidone—Dermatitis—Vinorelbine—ovarian cancer	0.00125	0.00363	CcSEcCtD
Primidone—Headache—Vinorelbine—ovarian cancer	0.00124	0.00361	CcSEcCtD
Primidone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00122	0.00353	CcSEcCtD
Primidone—Drowsiness—Epirubicin—ovarian cancer	0.0012	0.00348	CcSEcCtD
Primidone—Somnolence—Paclitaxel—ovarian cancer	0.00119	0.00345	CcSEcCtD
Primidone—Arthralgia—Docetaxel—ovarian cancer	0.00118	0.00343	CcSEcCtD
Primidone—Nausea—Vinorelbine—ovarian cancer	0.00118	0.00342	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00117	0.0034	CcSEcCtD
Primidone—Decreased appetite—Paclitaxel—ovarian cancer	0.00116	0.00337	CcSEcCtD
Primidone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00115	0.00335	CcSEcCtD
Primidone—Fatigue—Paclitaxel—ovarian cancer	0.00115	0.00334	CcSEcCtD
Primidone—Agranulocytosis—Epirubicin—ovarian cancer	0.00112	0.00324	CcSEcCtD
Primidone—Nervous system disorder—Docetaxel—ovarian cancer	0.00111	0.00322	CcSEcCtD
Primidone—Drowsiness—Doxorubicin—ovarian cancer	0.00111	0.00322	CcSEcCtD
Primidone—Skin disorder—Docetaxel—ovarian cancer	0.0011	0.00319	CcSEcCtD
Primidone—Anorexia—Docetaxel—ovarian cancer	0.00108	0.00313	CcSEcCtD
Primidone—Connective tissue disorder—Epirubicin—ovarian cancer	0.00106	0.00307	CcSEcCtD
Primidone—Visual impairment—Epirubicin—ovarian cancer	0.00104	0.00301	CcSEcCtD
Primidone—Agranulocytosis—Doxorubicin—ovarian cancer	0.00103	0.003	CcSEcCtD
Primidone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00103	0.00299	CcSEcCtD
Primidone—Somnolence—Docetaxel—ovarian cancer	0.00101	0.00292	CcSEcCtD
Primidone—Eye disorder—Epirubicin—ovarian cancer	0.00101	0.00292	CcSEcCtD
Primidone—Decreased appetite—Docetaxel—ovarian cancer	0.000985	0.00286	CcSEcCtD
Primidone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000978	0.00284	CcSEcCtD
Primidone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000978	0.00284	CcSEcCtD
Primidone—Fatigue—Docetaxel—ovarian cancer	0.000977	0.00283	CcSEcCtD
Primidone—Visual impairment—Doxorubicin—ovarian cancer	0.000959	0.00278	CcSEcCtD
Primidone—Asthenia—Paclitaxel—ovarian cancer	0.000959	0.00278	CcSEcCtD
Primidone—Mental disorder—Epirubicin—ovarian cancer	0.000942	0.00273	CcSEcCtD
Primidone—Malnutrition—Epirubicin—ovarian cancer	0.000936	0.00272	CcSEcCtD
Primidone—Eye disorder—Doxorubicin—ovarian cancer	0.00093	0.0027	CcSEcCtD
Primidone—Dizziness—Paclitaxel—ovarian cancer	0.000884	0.00256	CcSEcCtD
Primidone—Mental disorder—Doxorubicin—ovarian cancer	0.000872	0.00253	CcSEcCtD
Primidone—Malnutrition—Doxorubicin—ovarian cancer	0.000866	0.00251	CcSEcCtD
Primidone—Anaemia—Epirubicin—ovarian cancer	0.000865	0.00251	CcSEcCtD
Primidone—Vomiting—Paclitaxel—ovarian cancer	0.00085	0.00246	CcSEcCtD
Primidone—Rash—Paclitaxel—ovarian cancer	0.000843	0.00244	CcSEcCtD
Primidone—Dermatitis—Paclitaxel—ovarian cancer	0.000842	0.00244	CcSEcCtD
Primidone—Vertigo—Epirubicin—ovarian cancer	0.000841	0.00244	CcSEcCtD
Primidone—Headache—Paclitaxel—ovarian cancer	0.000837	0.00243	CcSEcCtD
Primidone—Asthenia—Docetaxel—ovarian cancer	0.000813	0.00236	CcSEcCtD
Primidone—Anaemia—Doxorubicin—ovarian cancer	0.000801	0.00232	CcSEcCtD
Primidone—Arthralgia—Epirubicin—ovarian cancer	0.000797	0.00231	CcSEcCtD
Primidone—Nausea—Paclitaxel—ovarian cancer	0.000794	0.0023	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000792	0.0023	CcSEcCtD
Primidone—Vertigo—Doxorubicin—ovarian cancer	0.000778	0.00226	CcSEcCtD
Primidone—Nervous system disorder—Epirubicin—ovarian cancer	0.000749	0.00217	CcSEcCtD
Primidone—Dizziness—Docetaxel—ovarian cancer	0.000749	0.00217	CcSEcCtD
Primidone—Skin disorder—Epirubicin—ovarian cancer	0.000742	0.00215	CcSEcCtD
Primidone—Arthralgia—Doxorubicin—ovarian cancer	0.000738	0.00214	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000732	0.00212	CcSEcCtD
Primidone—Anorexia—Epirubicin—ovarian cancer	0.000728	0.00211	CcSEcCtD
Primidone—Vomiting—Docetaxel—ovarian cancer	0.00072	0.00209	CcSEcCtD
Primidone—Rash—Docetaxel—ovarian cancer	0.000714	0.00207	CcSEcCtD
Primidone—Dermatitis—Docetaxel—ovarian cancer	0.000714	0.00207	CcSEcCtD
Primidone—Headache—Docetaxel—ovarian cancer	0.00071	0.00206	CcSEcCtD
Primidone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000696	0.00202	CcSEcCtD
Primidone—Nervous system disorder—Doxorubicin—ovarian cancer	0.000693	0.00201	CcSEcCtD
Primidone—Skin disorder—Doxorubicin—ovarian cancer	0.000687	0.00199	CcSEcCtD
Primidone—Somnolence—Epirubicin—ovarian cancer	0.000679	0.00197	CcSEcCtD
Primidone—Anorexia—Doxorubicin—ovarian cancer	0.000674	0.00195	CcSEcCtD
Primidone—Nausea—Docetaxel—ovarian cancer	0.000673	0.00195	CcSEcCtD
Primidone—Decreased appetite—Epirubicin—ovarian cancer	0.000664	0.00193	CcSEcCtD
Primidone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00066	0.00191	CcSEcCtD
Primidone—Fatigue—Epirubicin—ovarian cancer	0.000659	0.00191	CcSEcCtD
Primidone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000644	0.00187	CcSEcCtD
Primidone—Somnolence—Doxorubicin—ovarian cancer	0.000629	0.00182	CcSEcCtD
Primidone—Decreased appetite—Doxorubicin—ovarian cancer	0.000615	0.00178	CcSEcCtD
Primidone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00061	0.00177	CcSEcCtD
Primidone—Fatigue—Doxorubicin—ovarian cancer	0.00061	0.00177	CcSEcCtD
Primidone—Asthenia—Epirubicin—ovarian cancer	0.000548	0.00159	CcSEcCtD
Primidone—Asthenia—Doxorubicin—ovarian cancer	0.000507	0.00147	CcSEcCtD
Primidone—Dizziness—Epirubicin—ovarian cancer	0.000505	0.00147	CcSEcCtD
Primidone—Vomiting—Epirubicin—ovarian cancer	0.000486	0.00141	CcSEcCtD
Primidone—Rash—Epirubicin—ovarian cancer	0.000482	0.0014	CcSEcCtD
Primidone—Dermatitis—Epirubicin—ovarian cancer	0.000481	0.0014	CcSEcCtD
Primidone—Phenytoin—ABCB1—ovarian cancer	0.00048	0.189	CrCbGaD
Primidone—Headache—Epirubicin—ovarian cancer	0.000479	0.00139	CcSEcCtD
Primidone—Dizziness—Doxorubicin—ovarian cancer	0.000468	0.00136	CcSEcCtD
Primidone—Phenobarbital—ABCB1—ovarian cancer	0.00046	0.181	CrCbGaD
Primidone—Nausea—Epirubicin—ovarian cancer	0.000454	0.00132	CcSEcCtD
Primidone—Vomiting—Doxorubicin—ovarian cancer	0.00045	0.0013	CcSEcCtD
Primidone—Rash—Doxorubicin—ovarian cancer	0.000446	0.00129	CcSEcCtD
Primidone—Dermatitis—Doxorubicin—ovarian cancer	0.000445	0.00129	CcSEcCtD
Primidone—Headache—Doxorubicin—ovarian cancer	0.000443	0.00128	CcSEcCtD
Primidone—Nausea—Doxorubicin—ovarian cancer	0.00042	0.00122	CcSEcCtD
Primidone—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000132	0.00104	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000132	0.00104	CbGpPWpGaD
Primidone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000132	0.00104	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000132	0.00103	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000131	0.00103	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00013	0.00102	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00013	0.00102	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000129	0.00102	CbGpPWpGaD
Primidone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000128	0.00101	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000128	0.00101	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000127	0.000998	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000127	0.000994	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000126	0.000991	CbGpPWpGaD
Primidone—CHRNA7—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000126	0.00099	CbGpPWpGaD
Primidone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000126	0.000988	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000125	0.000981	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000124	0.000975	CbGpPWpGaD
Primidone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000124	0.000971	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000122	0.000958	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000122	0.000957	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—AKT1—ovarian cancer	0.000122	0.000955	CbGpPWpGaD
Primidone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000121	0.000947	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—MAPK1—ovarian cancer	0.00012	0.000945	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.00012	0.000942	CbGpPWpGaD
Primidone—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000117	0.00092	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000117	0.000915	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—NME2—ovarian cancer	0.000116	0.000911	CbGpPWpGaD
Primidone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000116	0.000909	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000115	0.000903	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000114	0.000897	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000113	0.000886	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000112	0.00088	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000111	0.000871	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000111	0.000868	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00011	0.000866	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00011	0.000862	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000108	0.000851	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000107	0.000843	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000107	0.000837	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—HRAS—ovarian cancer	0.000106	0.000834	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000106	0.000832	CbGpPWpGaD
Primidone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000106	0.000831	CbGpPWpGaD
Primidone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000106	0.000828	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000105	0.000826	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000105	0.000825	CbGpPWpGaD
Primidone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000103	0.000808	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000103	0.000807	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000103	0.000807	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000103	0.000807	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000103	0.000807	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000102	0.000803	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—MAPK1—ovarian cancer	0.000101	0.000794	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000101	0.000794	CbGpPWpGaD
Primidone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000101	0.000793	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.0001	0.000788	CbGpPWpGaD
Primidone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.93e-05	0.000779	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.92e-05	0.000778	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.88e-05	0.000775	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—NME2—ovarian cancer	9.83e-05	0.000771	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—MAPK1—ovarian cancer	9.82e-05	0.00077	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	9.72e-05	0.000763	CbGpPWpGaD
Primidone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.69e-05	0.00076	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—HRAS—ovarian cancer	9.67e-05	0.000758	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.64e-05	0.000756	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.63e-05	0.000756	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.47e-05	0.000743	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.3e-05	0.00073	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.07e-05	0.000712	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.82e-05	0.000692	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NME2—ovarian cancer	8.77e-05	0.000688	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.71e-05	0.000683	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	8.65e-05	0.000679	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	8.65e-05	0.000678	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	8.54e-05	0.00067	CbGpPWpGaD
Primidone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	8.47e-05	0.000665	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.42e-05	0.000661	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—MAPK1—ovarian cancer	8.42e-05	0.00066	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	8.34e-05	0.000654	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—MAPK1—ovarian cancer	8.31e-05	0.000652	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	8.26e-05	0.000648	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—HRAS—ovarian cancer	8.13e-05	0.000637	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NME2—ovarian cancer	8e-05	0.000628	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.97e-05	0.000625	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.93e-05	0.000622	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—HRAS—ovarian cancer	7.88e-05	0.000618	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.74e-05	0.000607	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—MAPK1—ovarian cancer	7.6e-05	0.000596	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.6e-05	0.000596	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYTB—ovarian cancer	7.48e-05	0.000587	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.47e-05	0.000586	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.44e-05	0.000584	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	7.43e-05	0.000583	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—MAPK1—ovarian cancer	7.39e-05	0.000579	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.29e-05	0.000572	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—MAPK1—ovarian cancer	7.25e-05	0.000569	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—MAPK1—ovarian cancer	7.13e-05	0.000559	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—MAPK1—ovarian cancer	6.95e-05	0.000545	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NME2—ovarian cancer	6.84e-05	0.000536	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.8e-05	0.000533	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.79e-05	0.000532	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—HRAS—ovarian cancer	6.76e-05	0.00053	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—HRAS—ovarian cancer	6.67e-05	0.000523	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—BRIP1—ovarian cancer	6.54e-05	0.000513	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PPP1CC—ovarian cancer	6.54e-05	0.000513	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.37e-05	0.0005	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYTB—ovarian cancer	6.33e-05	0.000497	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.19e-05	0.000486	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—HRAS—ovarian cancer	6.1e-05	0.000479	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—MAPK1—ovarian cancer	6.08e-05	0.000477	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.07e-05	0.000476	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—HRAS—ovarian cancer	5.93e-05	0.000465	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—HRAS—ovarian cancer	5.82e-05	0.000457	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.8e-05	0.000455	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—HRAS—ovarian cancer	5.72e-05	0.000449	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYTB—ovarian cancer	5.65e-05	0.000444	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—HRAS—ovarian cancer	5.58e-05	0.000438	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—BRIP1—ovarian cancer	5.54e-05	0.000434	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PPP1CC—ovarian cancer	5.54e-05	0.000434	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.53e-05	0.000434	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.53e-05	0.000434	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NME2—ovarian cancer	5.28e-05	0.000414	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYTB—ovarian cancer	5.16e-05	0.000404	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.04e-05	0.000395	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PPP1CC—ovarian cancer	4.94e-05	0.000388	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—BRIP1—ovarian cancer	4.94e-05	0.000388	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—HRAS—ovarian cancer	4.88e-05	0.000383	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.73e-05	0.000371	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—BRIP1—ovarian cancer	4.51e-05	0.000354	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PPP1CC—ovarian cancer	4.51e-05	0.000354	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYTB—ovarian cancer	4.41e-05	0.000346	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—YAP1—ovarian cancer	4.39e-05	0.000344	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.31e-05	0.000338	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.03e-05	0.000317	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—BRIP1—ovarian cancer	3.85e-05	0.000302	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PPP1CC—ovarian cancer	3.85e-05	0.000302	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—YAP1—ovarian cancer	3.71e-05	0.000291	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.68e-05	0.000288	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.6e-05	0.000283	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—FASN—ovarian cancer	3.58e-05	0.000281	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—SLC5A5—ovarian cancer	3.52e-05	0.000276	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYTB—ovarian cancer	3.4e-05	0.000267	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—SLC2A1—ovarian cancer	3.4e-05	0.000266	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—YAP1—ovarian cancer	3.31e-05	0.00026	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.28e-05	0.000258	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.28e-05	0.000257	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP1B1—ovarian cancer	3.26e-05	0.000255	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.23e-05	0.000253	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—FASN—ovarian cancer	3.03e-05	0.000237	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—YAP1—ovarian cancer	3.02e-05	0.000237	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.99e-05	0.000235	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—SLC5A5—ovarian cancer	2.98e-05	0.000234	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.97e-05	0.000233	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.97e-05	0.000233	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	2.89e-05	0.000227	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.88e-05	0.000226	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—SLC2A1—ovarian cancer	2.88e-05	0.000226	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.82e-05	0.000221	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.81e-05	0.00022	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP1B1—ovarian cancer	2.76e-05	0.000216	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—FASN—ovarian cancer	2.7e-05	0.000212	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ABCB1—ovarian cancer	2.68e-05	0.00021	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SLC5A5—ovarian cancer	2.66e-05	0.000209	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—TYMS—ovarian cancer	2.63e-05	0.000207	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.63e-05	0.000206	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—YAP1—ovarian cancer	2.58e-05	0.000203	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SLC2A1—ovarian cancer	2.57e-05	0.000201	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.56e-05	0.000201	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.51e-05	0.000197	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—FASN—ovarian cancer	2.46e-05	0.000193	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.46e-05	0.000193	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	2.45e-05	0.000192	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.43e-05	0.000191	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SLC5A5—ovarian cancer	2.42e-05	0.00019	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SLC2A1—ovarian cancer	2.34e-05	0.000184	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.29e-05	0.00018	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ABCB1—ovarian cancer	2.27e-05	0.000178	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.25e-05	0.000176	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP1B1—ovarian cancer	2.24e-05	0.000176	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—TYMS—ovarian cancer	2.23e-05	0.000175	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.18e-05	0.000171	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.17e-05	0.00017	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CAV1—ovarian cancer	2.12e-05	0.000167	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—FASN—ovarian cancer	2.11e-05	0.000165	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.07e-05	0.000162	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.03e-05	0.000159	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2e-05	0.000157	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—YAP1—ovarian cancer	1.99e-05	0.000156	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—TYMS—ovarian cancer	1.99e-05	0.000156	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.99e-05	0.000156	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.98e-05	0.000155	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.96e-05	0.000154	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CG—ovarian cancer	1.93e-05	0.000152	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.92e-05	0.00015	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.85e-05	0.000145	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—TYMS—ovarian cancer	1.81e-05	0.000142	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CAV1—ovarian cancer	1.8e-05	0.000141	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.72e-05	0.000135	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.7e-05	0.000133	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.7e-05	0.000133	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.69e-05	0.000133	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.64e-05	0.000128	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—FASN—ovarian cancer	1.62e-05	0.000127	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CAV1—ovarian cancer	1.6e-05	0.000126	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.6e-05	0.000125	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.58e-05	0.000124	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—TYMS—ovarian cancer	1.55e-05	0.000122	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.54e-05	0.000121	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.53e-05	0.00012	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.48e-05	0.000116	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.48e-05	0.000116	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CAV1—ovarian cancer	1.46e-05	0.000115	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.46e-05	0.000115	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1.44e-05	0.000113	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.4e-05	0.00011	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.33e-05	0.000105	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.31e-05	0.000103	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.28e-05	0.000101	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTEN—ovarian cancer	1.28e-05	0.0001	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CB—ovarian cancer	1.25e-05	9.84e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CAV1—ovarian cancer	1.25e-05	9.8e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.22e-05	9.56e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—TYMS—ovarian cancer	1.2e-05	9.39e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.19e-05	9.37e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.17e-05	9.19e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.14e-05	8.93e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.12e-05	8.78e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTEN—ovarian cancer	1.08e-05	8.5e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.02e-05	8.01e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1e-05	7.85e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTEN—ovarian cancer	9.67e-06	7.59e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CAV1—ovarian cancer	9.64e-06	7.57e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CA—ovarian cancer	9.03e-06	7.08e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTEN—ovarian cancer	8.82e-06	6.92e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	8.79e-06	6.89e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CB—ovarian cancer	8.72e-06	6.84e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	7.72e-06	6.06e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CA—ovarian cancer	7.65e-06	6e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTEN—ovarian cancer	7.54e-06	5.91e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—AKT1—ovarian cancer	7.38e-06	5.79e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CA—ovarian cancer	6.82e-06	5.35e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	6.73e-06	5.28e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—AKT1—ovarian cancer	6.25e-06	4.9e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CA—ovarian cancer	6.22e-06	4.88e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTEN—ovarian cancer	5.82e-06	4.56e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—AKT1—ovarian cancer	5.57e-06	4.37e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CA—ovarian cancer	5.32e-06	4.17e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—AKT1—ovarian cancer	5.08e-06	3.99e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—AKT1—ovarian cancer	4.34e-06	3.41e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	4.1e-06	3.22e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—AKT1—ovarian cancer	3.35e-06	2.63e-05	CbGpPWpGaD
